Pregnancy and breastfeeding: Tirzepatide is contraindicated for those planning pregnancies within the next 3 months, pregnant individuals, breastfeeding mothers, or mothers who have delivered a baby within the last 6 months
The goal is to help individuals lose weight in a safe and sustainable manner, and Tirzepatide plays a critical role in this process by suppressing appetite and improving insulin sensitivity
Scenario 3: clinical supervision with specific goals A healthcare provider who understands your full medical history might design a structured cycling protocol with specific objectives
Work with your healthcare provider: Your doctor can help you appeal the denial by providing supporting documentation, such as your medical history, treatment plans, and why tirzepatide is most appropriate for your health condition
A 200-pound person who carries weight primarily in their legs might have very little subcutaneous fat on their abdomen
doi: 10.1111/dom.14725 Mosenzon O, Garvey WT, Hesse D, et al